2021 Investor Day

Strong track record of execution and shareholder returns $2.1 Revenue ($B) +12% CAGR $3.2 $3.0 $2.6 $2.3 Non-GAAP Operating Income ($M) Non-GAAP EPS & Margin +18% CAGR +17% CAGR $994 $891 $716 $3.53 $3.64 $607 $2.82 $508 31% 30% 25% 26% 27% $5.33 $4.76 FY 2017 FY 2018 FY 2019 FY 2020 FY2021 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 NOTE: see reconciliation to GAAP in Appendix. Total Shareholder Return (TSR) (NYSE shares as of 6/30/2021): 1-yr 29% | 3-yr 146% | 5-yr 318% O2021 ResMed | 2021 Investor Day – Sept 8, 2021 - 80

View entire presentation